Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling

Jiro Ikeda, Toshihiro Ichiki, Hirohide Matsuura, E. Inoue Eriko, Junji Kishimoto, Aya Watanabe, Chikahiro Sankoda, Shiro Kitamoto, Tomotake Tokunou, Kotaro Takeda, Guo Hua Fong, Kenji Sunagawa

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background--Hypertension induces cardiovascular hypertrophy and fibrosis. Infiltrated macrophages are critically involved in this process. We recently reported that inhibition of prolyl hydroxylase domain protein 2 (PHD2), which hydroxylates the proline residues of hypoxia-inducible factor-a (HIF-α) and thereby induces HIF-α degradation, suppressed inflammatory responses in macrophages. We examined whether myeloid-specific Phd2 deletion affects hypertension-induced cardiovascular remodeling. Methods and Results--Myeloid-specific PHD2-deficient mice (MyPHD2KO) were generated by crossing Phd2-floxed mice with LysM-Cre transgenic mice, resulting in the accumulation of HIF-1α and HIF-2α in macrophage. Eight- to ten-week-old mice were given NG-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, and Angiotensin II (Ang II) infusion. L-NAME/ Ang II comparably increased systolic blood pressure in control and MyPHD2KO mice. However, MyPHD2KO mice showed less aortic medial and adventitial thickening, and macrophage infiltration. Cardiac interstitial fibrosis and myocyte hypertrophy were also significantly ameliorated in MyPHD2KO mice. Transforming growth factor-b and collagen expression were decreased in the aorta and heart from MyPHD2KO mice. Echocardiographic analysis showed that left ventricular hypertrophy and reduced ejection fraction induced by L-NAME/Ang II treatment in control mice were not observed in MyPHD2KO mice. Administration of digoxin that inhibits HIF-a synthesis to L-NAME/Ang II-treated MyPHD2KO mice reversed these beneficial features Conclusions--Phd2 deletion in myeloid lineage attenuates hypertensive cardiovascular hypertrophy and fibrosis, which may be mediated by decreased inflammation- and fibrosis-associated gene expression in macrophages. PHD2 in myeloid lineage plays a critical role in hypertensive cardiovascular remodeling.

Original languageEnglish
Article numbere000178
JournalJournal of the American Heart Association
Volume2
Issue number3
DOIs
Publication statusPublished - Sep 4 2013

Fingerprint

NG-Nitroarginine Methyl Ester
Angiotensin II
Macrophages
Fibrosis
Hypertrophy
Prolyl Hydroxylases
Blood Pressure
Hypertension
Hypoxia-Inducible Factor 1
Adventitia
Digoxin
Transforming Growth Factors
Left Ventricular Hypertrophy
Nitric Oxide Synthase Type II
Proline
Muscle Cells
Transgenic Mice
Aorta
Collagen
Inflammation

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling. / Ikeda, Jiro; Ichiki, Toshihiro; Matsuura, Hirohide; Inoue Eriko, E.; Kishimoto, Junji; Watanabe, Aya; Sankoda, Chikahiro; Kitamoto, Shiro; Tokunou, Tomotake; Takeda, Kotaro; Fong, Guo Hua; Sunagawa, Kenji.

In: Journal of the American Heart Association, Vol. 2, No. 3, e000178, 04.09.2013.

Research output: Contribution to journalArticle

Ikeda, J, Ichiki, T, Matsuura, H, Inoue Eriko, E, Kishimoto, J, Watanabe, A, Sankoda, C, Kitamoto, S, Tokunou, T, Takeda, K, Fong, GH & Sunagawa, K 2013, 'Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling', Journal of the American Heart Association, vol. 2, no. 3, e000178. https://doi.org/10.1161/JAHA.113.000174
Ikeda, Jiro ; Ichiki, Toshihiro ; Matsuura, Hirohide ; Inoue Eriko, E. ; Kishimoto, Junji ; Watanabe, Aya ; Sankoda, Chikahiro ; Kitamoto, Shiro ; Tokunou, Tomotake ; Takeda, Kotaro ; Fong, Guo Hua ; Sunagawa, Kenji. / Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling. In: Journal of the American Heart Association. 2013 ; Vol. 2, No. 3.
@article{b829eac0d2484171ae97127d24397b84,
title = "Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling",
abstract = "Background--Hypertension induces cardiovascular hypertrophy and fibrosis. Infiltrated macrophages are critically involved in this process. We recently reported that inhibition of prolyl hydroxylase domain protein 2 (PHD2), which hydroxylates the proline residues of hypoxia-inducible factor-a (HIF-α) and thereby induces HIF-α degradation, suppressed inflammatory responses in macrophages. We examined whether myeloid-specific Phd2 deletion affects hypertension-induced cardiovascular remodeling. Methods and Results--Myeloid-specific PHD2-deficient mice (MyPHD2KO) were generated by crossing Phd2-floxed mice with LysM-Cre transgenic mice, resulting in the accumulation of HIF-1α and HIF-2α in macrophage. Eight- to ten-week-old mice were given NG-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, and Angiotensin II (Ang II) infusion. L-NAME/ Ang II comparably increased systolic blood pressure in control and MyPHD2KO mice. However, MyPHD2KO mice showed less aortic medial and adventitial thickening, and macrophage infiltration. Cardiac interstitial fibrosis and myocyte hypertrophy were also significantly ameliorated in MyPHD2KO mice. Transforming growth factor-b and collagen expression were decreased in the aorta and heart from MyPHD2KO mice. Echocardiographic analysis showed that left ventricular hypertrophy and reduced ejection fraction induced by L-NAME/Ang II treatment in control mice were not observed in MyPHD2KO mice. Administration of digoxin that inhibits HIF-a synthesis to L-NAME/Ang II-treated MyPHD2KO mice reversed these beneficial features Conclusions--Phd2 deletion in myeloid lineage attenuates hypertensive cardiovascular hypertrophy and fibrosis, which may be mediated by decreased inflammation- and fibrosis-associated gene expression in macrophages. PHD2 in myeloid lineage plays a critical role in hypertensive cardiovascular remodeling.",
author = "Jiro Ikeda and Toshihiro Ichiki and Hirohide Matsuura and {Inoue Eriko}, E. and Junji Kishimoto and Aya Watanabe and Chikahiro Sankoda and Shiro Kitamoto and Tomotake Tokunou and Kotaro Takeda and Fong, {Guo Hua} and Kenji Sunagawa",
year = "2013",
month = "9",
day = "4",
doi = "10.1161/JAHA.113.000174",
language = "English",
volume = "2",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling

AU - Ikeda, Jiro

AU - Ichiki, Toshihiro

AU - Matsuura, Hirohide

AU - Inoue Eriko, E.

AU - Kishimoto, Junji

AU - Watanabe, Aya

AU - Sankoda, Chikahiro

AU - Kitamoto, Shiro

AU - Tokunou, Tomotake

AU - Takeda, Kotaro

AU - Fong, Guo Hua

AU - Sunagawa, Kenji

PY - 2013/9/4

Y1 - 2013/9/4

N2 - Background--Hypertension induces cardiovascular hypertrophy and fibrosis. Infiltrated macrophages are critically involved in this process. We recently reported that inhibition of prolyl hydroxylase domain protein 2 (PHD2), which hydroxylates the proline residues of hypoxia-inducible factor-a (HIF-α) and thereby induces HIF-α degradation, suppressed inflammatory responses in macrophages. We examined whether myeloid-specific Phd2 deletion affects hypertension-induced cardiovascular remodeling. Methods and Results--Myeloid-specific PHD2-deficient mice (MyPHD2KO) were generated by crossing Phd2-floxed mice with LysM-Cre transgenic mice, resulting in the accumulation of HIF-1α and HIF-2α in macrophage. Eight- to ten-week-old mice were given NG-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, and Angiotensin II (Ang II) infusion. L-NAME/ Ang II comparably increased systolic blood pressure in control and MyPHD2KO mice. However, MyPHD2KO mice showed less aortic medial and adventitial thickening, and macrophage infiltration. Cardiac interstitial fibrosis and myocyte hypertrophy were also significantly ameliorated in MyPHD2KO mice. Transforming growth factor-b and collagen expression were decreased in the aorta and heart from MyPHD2KO mice. Echocardiographic analysis showed that left ventricular hypertrophy and reduced ejection fraction induced by L-NAME/Ang II treatment in control mice were not observed in MyPHD2KO mice. Administration of digoxin that inhibits HIF-a synthesis to L-NAME/Ang II-treated MyPHD2KO mice reversed these beneficial features Conclusions--Phd2 deletion in myeloid lineage attenuates hypertensive cardiovascular hypertrophy and fibrosis, which may be mediated by decreased inflammation- and fibrosis-associated gene expression in macrophages. PHD2 in myeloid lineage plays a critical role in hypertensive cardiovascular remodeling.

AB - Background--Hypertension induces cardiovascular hypertrophy and fibrosis. Infiltrated macrophages are critically involved in this process. We recently reported that inhibition of prolyl hydroxylase domain protein 2 (PHD2), which hydroxylates the proline residues of hypoxia-inducible factor-a (HIF-α) and thereby induces HIF-α degradation, suppressed inflammatory responses in macrophages. We examined whether myeloid-specific Phd2 deletion affects hypertension-induced cardiovascular remodeling. Methods and Results--Myeloid-specific PHD2-deficient mice (MyPHD2KO) were generated by crossing Phd2-floxed mice with LysM-Cre transgenic mice, resulting in the accumulation of HIF-1α and HIF-2α in macrophage. Eight- to ten-week-old mice were given NG-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, and Angiotensin II (Ang II) infusion. L-NAME/ Ang II comparably increased systolic blood pressure in control and MyPHD2KO mice. However, MyPHD2KO mice showed less aortic medial and adventitial thickening, and macrophage infiltration. Cardiac interstitial fibrosis and myocyte hypertrophy were also significantly ameliorated in MyPHD2KO mice. Transforming growth factor-b and collagen expression were decreased in the aorta and heart from MyPHD2KO mice. Echocardiographic analysis showed that left ventricular hypertrophy and reduced ejection fraction induced by L-NAME/Ang II treatment in control mice were not observed in MyPHD2KO mice. Administration of digoxin that inhibits HIF-a synthesis to L-NAME/Ang II-treated MyPHD2KO mice reversed these beneficial features Conclusions--Phd2 deletion in myeloid lineage attenuates hypertensive cardiovascular hypertrophy and fibrosis, which may be mediated by decreased inflammation- and fibrosis-associated gene expression in macrophages. PHD2 in myeloid lineage plays a critical role in hypertensive cardiovascular remodeling.

UR - http://www.scopus.com/inward/record.url?scp=85052429907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052429907&partnerID=8YFLogxK

U2 - 10.1161/JAHA.113.000174

DO - 10.1161/JAHA.113.000174

M3 - Article

C2 - 23778187

AN - SCOPUS:85052429907

VL - 2

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 3

M1 - e000178

ER -